Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

SELL
$21.54 - $24.41 $12,924 - $14,646
-600 Reduced 4.71%
12,136 $275,000
Q2 2023

Jul 06, 2023

SELL
$12.62 - $24.47 $59,313 - $115,009
-4,700 Reduced 26.96%
12,736 $312,000
Q4 2022

Jan 12, 2023

BUY
$13.92 - $17.0 $242,709 - $296,412
17,436 New
17,436 $271,000

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Ardevora Asset Management LLP Portfolio

Follow Ardevora Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardevora Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Ardevora Asset Management LLP with notifications on news.